Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Activities of daily living: evaluation and treatment in persons with multiple sclerosis.
Focused suggestion with somatic anchoring technique: rapid self-hypnosis for pain management.
Regression-Based Norms Improve the Sensitivity of the National MS Society Consensus Neuropsychological Battery for Pediatric Multiple Sclerosis (NBPMS).
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis.
Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.
PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update.
Microbial colonization influences early B-lineage development in the gut lamina propria.
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.
Assessment of cerebral venous return by a novel plethysmography method.
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab For Relapsing-Remitting Multiple Sclerosis.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
Noninvasive molecular imaging of neuroinflammation.
Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination.
Effects of Gadolinium Contrast Agent Administration on Automatic Brain Tissue Classification of Patients with Multiple Sclerosis.
Multiple sclerosis and oligodendroglioma: an exceptional association.
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.

Pages